BackCrinetics Pharmaceuticals Overview

Crinetics Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for CRNX.

Quarterly EBIT

-$140.38M
↓ 26.01% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$535.67M
↓ 42.04% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin